Frown Lines

The "Botox® buzz" began with the discovery that the toxin somehow inhibited the ability to frown when injected between the eyebrows; now, Botox® has been used for cosmetic purposes for over 10 years and is the only BTX approved for cosmetic use in North America.

Two large clinical trials of 405 patients demonstrated that Botox® safely and effectively diminished frown lines (glabellar rhytides) for up to 4 months without any serious adverse effects (Carruthers 2002; Carruthers 2003).

Over 80% of study participants reported an improvement in their frown lines a week after injection; after 30 days, patients rated their glabellar lines much improved or non-existent. Improvements were still reported up to 4 months later.

On January 12, 2006, Health Canada approved BOTOX® Cosmetic for two new indications in the treatment of upper facial rhytides ("wrinkles"), including forehead and lateral canthus lines (Some people refer to them as "crows feet"). Treatment of glabellar lines was previously approved by Health Canada in 2001.

Click here to read more about how Botox® can help rejuvenate your face.
Click here to read more about treatments for lines and wrinkles.

Back to   Botox: Approved Indications Index